Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

The Lancet . December 06, 2022

Enlaces

https://doi.org/10.1016/S2213-8587(22)00319-9

Artículos Relacionadas

Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance

Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline

Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial

The effect of first intervention on cardiac parameters in patients with acromegaly: a systematic review

Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Transgender healthcare: metabolic outcomes and cardiovascular risk

The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline

Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study

Agenda

Julio 2025

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
30	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31	1	2	3

Top